SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
Kymera Therapeutics, Inc.
@KYMR_InsiderForm 4 Filing: Booth Bruce Sells $34.8M of $KYMR
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Kymera Therapeutics, Inc.
Ticker: $KYMR
Transaction Value
$34.8M
Price/Share: $121.86
transaction date
2026-06-25
Shares: 285,684
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Booth Bruce, holds the title of Director at Kymera Therapeutics, Inc..
On 2026-06-25, the insider transacted 285,684 shares.The shares were transacted at a weighted average price of $121.86 per share, resulting in a total market-relevant value of $34.8M.
Executive Summary Summary
Booth Bruce (Director) sold $34.8M of $KYMR
Post-Transaction Position: 2,963,607 shares
SEC Accession No: 0001451612-26-000016 (CIK: 1451612)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.